Copyright © 2026 Authors retain the copyright of this article. This article is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

@article{185039,
        author = {Dr Sujitha},
        title = {Psychedelic-Assisted Therapy – A Modern Approach to Mental Health Treatment},
        journal = {International Journal of Innovative Research in Technology},
        year = {2025},
        volume = {12},
        number = {5},
        pages = {211-213},
        issn = {2349-6002},
        url = {https://ijirt.org/article?manuscript=185039},
        abstract = {Psychedelic-assisted therapy (PAT) has started being recognized as a potential treatment approach for various psychiatric conditions, including depression, post traumatic stress disorder (PTSD), and substance abuse disorders. In this review, we focus on the appreciative inquiry approach with the history of therapeutic psychedelics, the neuropsychobiological parts of it, and the clinical application of psychedelics in medicine. Clinical trials of psilocybin, MDMA, and ketamine, have generally shown a high degree of effectiveness, producing both rapid and long lasting symptom mitigation where traditional methods have failed. The therapies have been made possible through steps such as increase in neuroplasticity, change in the pattern of serotonin receptor interaction, and processing of emotion and memory. In addition, the provided patient-centered therapeutic environment is essential for an effective and safe therapeutic process. These findings, which are novel to many practitioners, bring up new challenges. The barriers of regulation, risk ethics, and the insufficiency of treatment guidelines pose significant concern. Research is still ongoing on these treatments to develop better models, broaden accessibility, and minimize risks. Mental healthcare can be transformed with the use of PAT as these new methods can assist with disorders that are hard to treat. This review synthesizes current findings and discusses future directions, emphasizing the importance of continued research, policy advancements, and clinical integration to maximize the therapeutic benefits of psychedelics.},
        keywords = {},
        month = {September},
        }